Roche has started its financial reporting for 2026 with a 5% fall in first-quarter revenues, but says its underlying performance remains strong.
Endpoints wins Neal Awards for Trump and gene editing coverage, JPM event
Endpoints News was recognized with three 2026 Neal Awards for its coverage of the drug industry’s relationship with the Trump administration, a three-part series on


